Champions Oncology to Announce First Quarter Financial Results on Monday, September 14, 2020

HACKENSACK, NJ / ACCESSWIRE / September 8, 2020 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced it will report its financial and operational results for the first quarter ended July 31, 2020, on Monday, September 14, 2020, after market close. The company will host a conference call to discuss the results that day at 4:30 p.m. EDT (1:30 p.m. PDT). To join the call dial 877-407-8035 (Domestic) or 201-689-8035 (International). A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering Passcode: 37498, or by accessing the Investors section of the company’s website within 72 hours.

About Champions Oncology, Inc.
Champions Oncology, Inc. is engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs. The Company’s technology platform is a novel approach to personalizing cancer care based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting engraftments, or Champions TumorGrafts, in a manner that preserves the biological characteristics of the original human tumor in order to determine the efficacy of a treatment regimen. The Company uses this technology in conjunction with related services to offer solutions for pharmaceutical and biotechnology companies seeking personalized approaches to drug development that can lower the cost and increase the speed of developing new drugs. TumorGrafts are procured through agreements with a number of institutions in the U.S. and overseas, as well as from TumorGraft study patients, where results are used to help guide the development of personalized treatment plans for the individual. For more information, visit Champions Oncology, Inc’s website (www.championsoncology.com).

SOURCE: Champions Oncology, Inc.

View source version on accesswire.com:
https://www.accesswire.com/605218/Champions-Oncology-to-Announce-First-Quarter-Financial-Results-on-Monday-September-14-2020

Staff

Recent Posts

Journal of Cardiac Failure December Issue Showcases Innovations in Transplant Care, Digital Therapeutics, and Global Heart Failure Treatment Strategies

WASHINGTON, Dec. 9, 2025 /PRNewswire/ -- The December issue of the Journal of Cardiac Failure (JCF),…

24 minutes ago

PhyxUp Health Leads Innovation in US Rehabilitation Market with AI-Powered Remote Therapeutic Monitoring(RTM), Launches $1M Seed Funding Round

SAN FRANCISCO, Dec. 9, 2025 /PRNewswire/ -- PhyxUp Health, an AI-driven Remote Therapeutic Monitoring (RTM) platform…

24 minutes ago

BestQool Launches Christmas Campaign Crossing Into 2026 Before the Next Wave of New Product Updates

NEW YORK, Dec. 9, 2025 /PRNewswire/ -- BestQool is now giving a holiday offer to…

24 minutes ago

Eagle Merchant Partners Portfolio Company Aligned Fitness Acquires 13 Club Pilates Studios

ATLANTA, Dec. 9, 2025 /PRNewswire/ -- Eagle Merchant Partners portfolio company, Aligned Fitness, has recently completed…

24 minutes ago

Kontakt.io Introduces Access Agent to Boost Outpatient Clinic Efficiency By Up To 20% With AI

First-of-its-kind AI Agent provides real-time insights into exam room utilization, ensuring patients experience shorter wait…

25 minutes ago

Westchester Medical Center and Good Samaritan Hospital Recognized as Top Maternity Hospitals by U.S. News & World Report

VALHALLA, N.Y., Dec. 9, 2025 /PRNewswire/ -- U.S. News & World Report (U.S. News) has…

25 minutes ago